Embedded Files
Atogepant (Qulipta®): A daily preventive medication for migraine
Atogepant (Qulipta®): A daily preventive medication for migraine
Atogepant (Qulipta®) is an oral medication used to prevent migraine attacks. It belongs to a class of treatments called gepants, which are small molecule oral CGRP antagonists.
At the Ottawa Headache Centre, we use atogepant (Qulipta®) in carefully selected patients as part of a structured migraine prevention strategy, with clear expectations around response timelines, outcome tracking, and insurance navigation.
Looking for a detailed medication handout of Qulipta®? Explore our downloadable handouts created by the specialists at the Ottawa Headache Centre.
Accessing atogepant (Qulipta®) in Ottawa
Accessing atogepant (Qulipta®) in Ottawa
Who may benefit from atogepant (Qulipta®)?
Who may benefit from atogepant (Qulipta®)?
Atogepant (Qulipta®) is used for the prevention of episodic or chronic migraine.
It is taken daily, regardless of whether you have a headache.
Atogepant (Qulipta®) is a medication we consider when:
Patients continue to have frequent migraine attacks after trying two oral preventives
Pregnancy planning may be in the near future, and a medication that can be discontinued quickly is preferred
There is a preference for daily oral medications over injectable treatments
How do you access atogepant (Qulipta®) in Ottawa?
How do you access atogepant (Qulipta®) in Ottawa?
In Ontario, coverage for atogepant (Qulipta ®) often requires:
A diagnosis of episodic or chronic migraine
Documentation of migraine frequency
Trials of at least two oral preventive medications at therapeutic doses (usually for ~3 months each, depending on insurer)
People without private insurance may be eligible to have the cost of atogepant (Qulipta ®) reimbursed through an application to the Exceptional Access Program (this can be done by any doctor).
At the Ottawa Headache Centre we will:
Confirm your diagnosis and migraine burden
Determine whether atogepant (Qulipta®) is an appropriate option, and offer alternatives
Discuss the evidence backing atogepant (Qulipta®), its benefits, as well as side-effects
Assist with any insurance forms
Complete the prior authorization process that is needed
Next steps to get started on atogepant (Qulipta®) in Ottawa
Next steps to get started on atogepant (Qulipta®) in Ottawa
If you feel like you are getting nowhere with your migraine preventives, ask your doctor for a referral to the Ottawa Headache Centre and we will explore migraine-specific preventive options with you.
Atogepant (Qulipta®) and its effect on migraine
Atogepant (Qulipta®) and its effect on migraine
Atogepant (Qulipta®) blocks the action of CGRP, a chemical involved in migraine pain signaling.
By reducing CGRP activity, atogepant (Qulipta®):
Lowers the likelihood that a migraine attack will occur.
Decreases the severity and duration of migraine attacks.
Makes migraine attacks more susceptible to acute medications (i.e., easier to treat).
Next steps
Next steps
Atogepant (Qulipta®) can be a strong option for migraine prevention, but the right choice depends on your diagnosis, migraine pattern, prior treatment history, preferences, and lifestyle values.
If you are considering Qulipta® (or have been referred), our consultation helps:
confirm whether atogepant fits your migraine profile
set realistic timelines for judging response
and place it into a broader, individualized care plan (including acute and non-medication strategies).
Ask your doctor for a referral to the Ottawa Headache Centre if you want to learn more about your migraine-specific preventive options.
Common questions about atogepant (Qulipta®)
Common questions about atogepant (Qulipta®)
How quickly does atogepant (Qulipta®) take to work?
How quickly does atogepant (Qulipta®) take to work?
Atogepant (Qulipta®) is taken once daily by mouth regardless of whether there is a headache or not. It can be taken with or without food.
Some people notice improvement within days of starting atogepant (Qulipta®). The majority of people notice improvement within a few weeks.
What are the side effects of atogepant (Qulipta®)?
What are the side effects of atogepant (Qulipta®)?
Atogepant (Qulipta®) is generally well tolerated.
Possible side effects include:
Constipation
Nausea
Fatigue
Weight-loss (in some patients)
Serious side effects are uncommon.
Can atogepant (Qulipta®) be used during pregnancy?
Can atogepant (Qulipta®) be used during pregnancy?
Not currently.
Atogepant (Qulipta®) is not recommended during pregnancy due to limited safety data.
If pregnancy is planned:
Atogepant (Qulipta®) should be stopped at least 1 week before pregnancy
This allows time for the medication to fully clear from the body.
If you are pregnant or planning pregnancy, we will help you find alternative migraine strategies.
Can atogepant (Qulipta®) be used during breastfeeding or lactation?
Can atogepant (Qulipta®) be used during breastfeeding or lactation?
Data on gepant use and breastfeeding are limited but growing. Small case series suggest the amount of gepants - including atogepant (Qulipta®) in breastmilk is small.
We help guide the discussion around gepant-use during breastfeeding and lactation to help you make an informed decision.
Is the cost of atogepant (Qulipta®) covered in Ontario?
Is the cost of atogepant (Qulipta®) covered in Ontario?
In Ontario, coverage for atogepant (Qulipta ®) often requires:
A diagnosis of episodic or chronic migraine
Documentation of migraine frequency
Trials of at least two oral preventive medications at therapeutic doses (usually for ~3 months each, depending on insurer)
People without private insurance may be eligible to have the cost of atogepant (Qulipta ®) reimbursed through an application to the Exceptional Access Program (this can be done by any doctor).
We assist with:
Insurance forms
Prior authorization
Can atogepant (Qulipta®) be combined with other treatments?
Can atogepant (Qulipta®) be combined with other treatments?
From a medical perspective, atogepant (Qulipta®) can be used:
Alone
Alongside other oral preventive medications
Concurrently with Botox® for chronic migraine, although insurers will typically not cover both
Insurance plans may restrict coverage of combination advanced therapies.
Can atogepant (Qulipta®) be combined with acute gepants like ubrogepant (Ubrelvy®) or rimegepant (Nurtec®)?
Can atogepant (Qulipta®) be combined with acute gepants like ubrogepant (Ubrelvy®) or rimegepant (Nurtec®)?
Atogepant (Qulipta®) has been demonstrated to be safe when combined with ubrogepant (Ubrelvy®), although constipation may be more common. Data are lacking regarding safety and efficacy of combining atogepant (Qulipta®) for migraine prevention with rimegepant (Nurtec®) for acute migraine attacks.
If I did not respond to CGRP monoclonal antibodies, does this mean that atogepant (Qulipta®) will not work for me?
If I did not respond to CGRP monoclonal antibodies, does this mean that atogepant (Qulipta®) will not work for me?
No.
For many people it takes a few trials to find the most effective migraine preventive, and some people who have not responded to CGRP monoclonal antibodies may still derive benefit from atogepant (Qulipta®).
If I did not respond to atogepant (Qulipta®), does that mean that CGRP monoclonal antibodies will not work for me?
If I did not respond to atogepant (Qulipta®), does that mean that CGRP monoclonal antibodies will not work for me?
No.
For many people it takes a few trials to find the most effective migraine preventive, and some people who have not responded to atogepant (Qulipta®) will still respond to CGRP monoclonal antibodies.
Disclaimer
Disclaimer
This material is provided for educational purposes and does not replace independent clinical judgment or institutional protocols. Management decisions remain the responsibility of the treating clinician.
Page updated
Google Sites
Report abuse